Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Hikma Pharmaceuticals Plc ADR (HKMPY)

Hikma Pharmaceuticals Plc ADR (HKMPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 17.65
  • Price/Book 6.06
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.6400 +8.10%
on 09/24/24
52.5800 unch
on 10/17/24
+2.0800 (+4.12%)
since 09/17/24
3-Month
47.8405 +9.91%
on 08/06/24
55.5600 -5.36%
on 08/16/24
+3.5800 (+7.31%)
since 07/17/24
52-Week
42.2300 +24.51%
on 11/16/23
55.5600 -5.36%
on 08/16/24
+0.2600 (+0.50%)
since 09/29/23

Most Recent Stories

More News
Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

/CNW/ -- Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire...

HKMPY : 52.5800 (+0.63%)
Bio-Thera Solutions and Hikma Pharmaceuticals Announce Exclusive Commercialization and License Agreement for BAT2206 in the US, a Proposed Biosimilar Referencing Stelara® (ustekinumab)

Bio-Thera Solutions, Ltd. (688177.SH) and Hikma Pharmaceuticals PLC (LSE: HIK) today announced that they have entered into a commercialization and license agreement to commercialize BAT2206, a monoclonal...

HIK.LN : 2,000.123 (-0.89%)
HKMPY : 52.5800 (+0.63%)
Melinta Therapeutics and Hikma Sign Exclusive Licensing Agreement for Two Novel Anti-Infectives for the Middle East and North Africa Region

Melinta Therapeutics (Melinta) and Hikma Pharmaceuticals PLC (Hikma) today announced they have entered into an exclusive licensing agreement for Vabomere ® (meropenem and vaborbactam) and Orbactiv ®...

HIK.LN : 2,000.123 (-0.89%)
HKMPY : 52.5800 (+0.63%)
Sesen Bio Announces Partnership with Hikma Pharmaceuticals for the Commercialization of Vicineumâ„¢ in the Middle East and North Africa

Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and Hikma Pharmaceuticals, a multi-national pharmaceutical...

SESN : 12.5760 (+7.29%)
HIK.LN : 2,000.123 (-0.89%)
HKMPY : 52.5800 (+0.63%)

Business Summary

Hikma Pharmaceuticals PLC was incorporated on September 8, 2005. The Company, together with its subsidiaries, is engaged in the development, manufacture and marketing of a broad range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms. Its...

See More

Key Turning Points

3rd Resistance Point 52.5800
2nd Resistance Point 52.5800
1st Resistance Point 52.5800
Last Price 52.5800
1st Support Level 52.5800
2nd Support Level 52.5800
3rd Support Level 52.5800

See More

52-Week High 55.5600
Last Price 52.5800
Fibonacci 61.8% 50.4679
Fibonacci 50% 48.8950
Fibonacci 38.2% 47.3221
52-Week Low 42.2300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar